Roscovitine inhibits thyroid hormone-induced tail regression of the frog tadpole and reveals a role for cyclin C/Cdk8 in the establishment of the metamorphic gene expression program

Developmental Dynamics

Volumn 237, Issue 12, 2008, Pages 3787-3797

  Skirrow, Rachel C ^a   Veldhoen, Nik ^a   Domanski, Dominik ^a   Helbing, Caren C ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Cyclin; Cyclin dependent kinase; Frog metamorphosis; Protein phosphorylation; Thyroid hormone

Indexed keywords

CELL ANTIGEN; CYCLIN C; CYCLIN DEPENDENT KINASE 8; CYCLIN DEPENDENT KINASE INHIBITOR; LIOTHYRONINE; ROSCOVITINE; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EARLY RESPONSE GENE; FROG; GENE EXPRESSION; METAMORPHOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TADPOLE; TAIL;

ANIMALS; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LARVA; METAMORPHOSIS, BIOLOGICAL; PHOSPHORYLATION; PURINES; RANIDAE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TAIL; THYROID HORMONES; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION, GENETIC;

ANURA; RANA CATESBEIANA;

EID: 57149113568     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21800     Document Type: Article

References (76)

1. Adachi S, Ito H, Tamamori-Adachi M, Ono Y, Nozato T, Abe S, Ikeda M, Marumo F, Hiroe M. 2001. Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res 88:408-414.
2. Akoulitchev S, Chulkov S, Reinberg D. 2000. TFIIH is negatively regulated by cdk8-containing complexes. Nature 407:102-106.
3. Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E. 1998. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp Cell Res 245:8-18.
4. Atienza C Jr, Elliott MJ, Dong YB, Yang HL, Stilwell A, Liu TJ, McMasters KM. 2000. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Int J Mol Med 6:55-63.
5. Berthet C, Kaldis P. 2007. Cell-specific responses to loss of cyclin-dependent kinases. Oncogene 26:4469-4477.
6. Bortner D, Rosenberg M. 1995. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Differ 6:1579-1589.
7. Bregman DB, Pestell R, Kidd V. 2000. Cell cycle regulation and RNA polymerase II. Front Biosci 5:244-257.
8. Brown DD, Wang Z, Furlow JD, Kanamori A, Schwartzman RA, Remo BF, Pinder A. 1996. The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis. Proc Natl Acad Sci U S A 93:1924-1929.
9. Chen S, Chang Y, Wu Y, Lin K. 2003. Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology 144:1407-1419.
10. Chi Y, Huddleston M, Zhang X, Young R, Annan R, Carr S, Deshaies R. 2001. Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev 15:1078-1092.
11. Choi KS, Eom YW, Kang Y, Ha MJ, Rhee H, Yoon JW, Kim SJ. 1999. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells. J Biol Chem 274:31775-31783.
12. David-Pfeuty T. 1999. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells. Oncogene 18:7409-7422.
13. De Azevedo WF Jr, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E, Kim SH. 1996. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci U S A 93:2735-2740.
14. Dobashi Y, Shoji M, Kondo E, Akiyama T, Kameya T. 1998. CDK4, a possible critical regulator of apoptosis in rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun 253:609-613.
15. Eliceiri B, Brown D. 1994. Quantitation of endogenous thyroid hormone receptors a and b during embryogenesis and metamorphosis in Xenopus laevis. J Biol Chem 269:24459-24465.
16. Fondell J, Ge H, Roeder R. 1996. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A 93:8329-8333.
17. Giardina SF, Beart PM. 2002. Kainate receptor-mediated apoptosis in primary cultures of cerebellar granule cells is attenuated by mitogen-activated protein and cyclin-dependent kinase inhibitors. Br J Pharmacol 135:1733-1742.
18. Gil-Gomez G, Berns A, Brady H. 1998. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 17:7209-7218.
19. Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG. 1998. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281:533-538.
20. Hajduch M, Havlieek L, Vesely J, Novotny R, Mihal V, Strnad M. 1999. Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Adv Exp Med Biol 457:341-353.
21. Harvey C, Williams G. 2002. Mechanism of thyroid hormone action. Thyroid 12:441-446.
22. Helbing CC, Atkinson BG. 1994. 3,5,3′-Triiodothyronine-induced carbamyl phosphate synthetase gene expression is stabilized in the liver of Rana catesbeiana tadpoles during heat shock. J Biol Chem 269:11743-11750.
23. Helbing CC, Gergely G, Atkinson BG. 1992. Sequential up-regulation of thyroid hormone b receptor, ornithine transcarbamylase and carbamyl phosphate synthetase mRNAs in the liver of Rana catesbeiana tadpoles during spontaneous and thyroid hormone-induced metamorphosis. Dev Genet 13:289-301.
24. Helbing C, Gallimore C, Atkinson BG. 1996. Characterization of a Rana catesbeiana Hsp30 gene and its expression in the liver of this amphibian during both spontaneous and thyroid hormone-induced metamorphosis. Dev Genet 18:223-233.
25. Helbing CC, Wellington CL, Gogela-Spehar M, Cheng T, Pinchbeck G, Johnston RN. 1998. Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle. Oncogene 17:1491-1501.
26. Helbing C, Werry K, Crump D, Domanski D, Veldhoen N, Bailey C. 2003. Expression profiles of novel thyroid hormone-responsive genes and proteins in the tail of Xenopus laevis tadpoles undergoing precocious metamorphosis. Mol Endocrinol 17:1395-1409.
27. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ. 1999. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 103:597-604.
28. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci U S A 91:6875-6879.
29. Ji L, Domanski D, Skirrow R, Helbing C. 2007. Genistein prevents thyroid hormone-dependent tail regression of Rana catesbeiana tadpoles by targetting protein kinase C and thyroid hormone receptor alpha. Dev Dyn 236:777-790.
30. Jones K, Brubaker J, Chin WW. 1994. Evidence that phosphorylation events participate in thyroid hormone action. Endocrinology 134:543-548.
31. Kanamori A, Brown D. 1993. Cultured cells as a model for amphibian metamorphosis. Proc Natl Acad Sci U S A 90:6013-6017.
32. Kawahara A, Baker B, Tata J. 1991. Developmental and regional expression of thyroid hormone receptor genes during Xenopus metamorphosis. Development 112:933-943.
33. Kuno-Murata M, Koibuchi N, Fukuda H, Murata M, Chin WW. 2000. Augmentation of thyroid hormone receptor-mediated transcription by Ca2+/calmodulin-dependent protein kinase type IV. Endocrinology 141:2275-2278.
34. Laemmli U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
35. Lee K-Y, Helbing CC, Choi K-S, Johnston RN, Wang JH. 1997. Neuronal cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 272:5622-5626.
36. Levkau B, Koyama H, Rains E, Clurman B, Herren B, Orth K, Roberts J, Ross R. 1998. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1:553-563.
37. Maas JW Jr, Horstmann S, Borasio GD, Anneser JM, Shooter EM, Kahle PJ. 1998. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors. J Neurochem 70:1401-1410.
38. Malik S, Roeder R. 2000. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. Trends Biochem Sci 25:277-283.
39. Meijer L, Borgne A, Mulner O, Chong J, Blow J, Inagki N, Inagaki M, Delcros J, Moulinoux J. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536.
40. Meikrantz W, Schlegel R. 1996. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271:10205-10209.
41. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R. 1994. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A 91:3754-3758.
42. Mgbonyebi OP, Russo J, Russo IH. 1999. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res 59:1903-1910.
43. Minshull J, Sun H, Tonks NK, Murray AW. 1994. A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts. Cell 79:475-486.
44. Nelson C, Goto S, Lund K, Hung W, Sadowski I. 2003. Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12. Nature 421:187-190.
45. Padmanabhan J, Park DS, Greene LA, Shelanski ML. 1999. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neurosci 19:8747-8756.
46. Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA. 1998. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 143:457-467.
47. Pinhero R, Liaw P, Bertens K, Yankulov K. 2004. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II. Eur J Biochem 271:1004-1014.
48. Pippin JW, Qu Q, Meijer L, Shankland SJ. 1997. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100:2512-2520.
49. Puzianowska-Kuznicka M, Wong J, Kanamori A, Shi Y. 1996. Functional characterization of a mutant thyroid hormone receptor in Xenopus laevis. J Biol Chem 271:33394-33403.
50. Ranjan M, Wong J, Shi Y. 1994. Transcriptional repression of Xenopus TR beta gene is mediated by a thyroid hormone response element located near the start site. J Biol Chem 269:24699-24705.
51. Rickert P, Corden J, Lees E. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18:1093-1102.
52. Rosenfeld MG, Glass CK. 2001. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868.
53. Sachs LM, Damjanovski S, Jones PL, Li Q, Amano T, Ueda S, Shi Y-B, Ishizuya-Oka A. 2000. Dual functions of thyroid hormone receptors during Xenopus development. Comp Biochem Physiol Part B 126:199-211.
54. Sausville E. 2002. Complexities in the development of cyclin-dependent kinase inhibitor drugs. Trends Mol Med 8:S32-S37.
55. Schang LM, Rosenberg A, Schaffer PA. 2000. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol 74:2107-2120.
56. Senderowicz AM, Sausville EA. 2000. Preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst 92:376-387.
57. Shi Y-B. 2000. Amphibian metamorphosis: from morphology to molecular biology. New York: Wiley-Liss.
58. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH. 1994. Premature p34cdc2 activation required for apoptosis. Science 263:1143-1145.
59. Skirrow R, Helbing CC. 2007. Decreased cyclin dependent kinase activity promotes thyroid hormone-dependent tail regression in Rana catesbeiana. Cell Tissue Res 328:281-289.
60. Tautz D, Renz M. 1983. An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels. Anal Biochem 132:14-19.
61. Taylor AC, Kollros JJ. 1946. Stages in the normal development of Rana pipiens larvae. Anat Rec 94:7-24.
62. Ting Y-T, Bhat MK, Wong R, Cheng S-y. 1997. Tissue-specific stabilization of the thyroid hormone beta1 nuclear receptor by phosphorylation. J Biol Chem 272:4129-4134.
63. Tzagarakis-Foster C, Privalsky M. 1998. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J Biol Chem 273:10926-10932.
64. Veldhoen N, Helbing CC. 2001. Detection of environmental endocrine-disruptor effects on gene expression in live Rana catesbeiana tadpoles using a tail fin biopsy technique. Environ Toxicol Chem 20:2704-2708.
65. Veldhoen N, Crump D, Werry K, Helbing C. 2002. Distinctive gene profiles occur at key points during natural metamorphosis in the Xenopus laevis tadpole tail. Dev Dyn 225:457-468.
66. Veldhoen N, Skirrow R, Ji L, Domanski D, Bonfield E, Bailey C, Helbing C. 2006. Use of heterologous cDNA arrays and organ culture in the detection of thyroid hormone-dependent responses in a sentinel frog, Rana catesbeiana. Comp Biochem Physio D 1:187-199.
67. Wagner MJ, Gogela-Spehar M, Skirrow RC, Johnston RN, Riabowol K, Helbing CC. 2001. Expression of novel ING variants is regulated by thyroid hormone in the Xenopus laevis tadpole. J Biol Chem 276:47013-47020.
68. Wang Z, Brown DD. 1993. Thyroid hormone-induced gene expression program for amphibian tail resorption. J Biol Chem 268:16270-16278.
69. Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Stein D, Denny T, Harrison LE, Meijer L, Kashanchi F. 2001. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. J Virol 75:7266-7279.
70. Worland PJ, Kaur G, Stetler-Stevenson M, Sebers S, Sartor O, Sausville EA. 1993. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity. Biochem Pharmacol 46:1831-1840.
71. Yakisich JS, Boethius J, Lindblom IO, Wallstedt L, Vargas VI, Siden A, Cruz MH. 1999. Inhibition of DNA synthesis in human gliomas by roscovitine. Neuroreport 10:2563-2567.
72. Yao S, McKenna K, Sharkis S, Bedi A. 1996. Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases. Cancer Res 56:4551-4555.
73. Yaoita Y, Shi Y, Brown D. 1990. Xenopus laevis alpha and beta thyroid hormone receptors. Proc Natl Acad Sci U S A 87:7090-7094.
74. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
75. Yen PM. 2006. Thyroid hormones and 3,5-diiodothyropropionic acid: new keys for new locks. Endocrinology 147:1598-1601.
76. Zhang J, Lazar M. 2000. The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466.